1 1 1 0 0 behavior, we employed another widely used stress model: the chronic social defeat stress (CSDS) 1 0 1 paradigm (Supplementary Fig. S1D ). Adult C57BL/6J mice that were subjected to CSDS were 1 0 2 separated into susceptible and resilient subpopulations (Supplementary Fig. S1E) . A physiological 1 0 3 concentration of MGO (10 μ M, lateral intracerebroventricular (i.c.v.) infusion) decreased the total duration 1 0 4 of immobility in adult C57BL6/J mice. Notably, a preinfusion of aminoguanidine, a scavenger of free 1 0 5 MGO, blocked MGO's antidepressant-like effects ( Fig. 1H and 1I) . We then considered whether MGO 1 0 6 could reverse CSDS-induced social avoidance, which is a model of stress-induced psychopathology in 1 0 7 humans 20,21 . After a 10-d CSDS protocol, the mice that were treated with vehicle exhibited an 1 0 8 approximately 70% reduction in time spent in the interaction zone. In contrast, a 7-d treatment with MGO 1 0 9 reversed the defeat-related behaviors in mice after CSDS ( Fig. 1H ), suggesting that MGO promotes 1 1 0 resilience to chronic stress in adult mice. To validate the RNA-seq results, we focused on the genes associated with synaptic plasticity and 1 3 4 neurogenesis, using qRT-PCR and immunofluorescence analyses ( Fig. 2D and Supplementary Fig. 1F ).
3 5
The results showed that MGO's regulation on the expression of these genes is in accordance with RNA-1 3 6 seq results. Of note, gamma-aminobutyric acid type A receptor related genes (Gabra1, Gabarapl2) in HC, 1 3 7 which were previously implicated in anxious and depression 15, 16 were upregulated by MGO compared to 1 3 8 CMS group. 5-hydroxytryptamine receptor 2A (Htr2a), mutations of which are associated with response 1 3 9 to the antidepressant citalopram in MDD patients 23 , is downregulated by MGO in the PFC region. In 1 4 0 addition, MGO also significantly up-regulated the mRNA expression levels of Bdnf and Adam22 that are 1 4 1 involved in the positive regulation of neurogenesis ( Fig. 2D) . To test whether MGO modulates 1 4 2 hippocampal neurogenesis in vivo, we carried out immunofluorescence analysis on the HC slices of 1 4 3 CMS rats treated with MGO. The density of both BrdU+ new born neurons and BrdU+/NeuN+ neurons 1 4 4 was decreased in the hippocampal dentate gyrus (DG) of CMS rats (Supplementary Fig. 1F ). Whereas 1 4 5 ip administration of MGO significantly increased the proportion of these cells (Supplementary Fig. 1F ), 1 4 6 indicating that MGO is capable of promoting hippocampal neurogenesis in CMS rats. Together these 1 4 7 data suggest that MGO promotes the synaptic plasticity in PFC and hippocampal neurogenesis in CMS 
7 3
Forced swim test In brief, SD rats were placed in a glass cylinder filled with water (23°C; 30 cm deep) 3 7 4 and a 5-min swim test session was video-recorded. Employing an automated video tracking system, the 3 7 5 time spent immobile during the last 4 minutes of the test and the latency to immobility were scored. An 3 7 6 increase in immobility time indicates a higher degree of depressive state. All tests were analyzed by 3 7 7
TopScan (CleverSys, Inc., CSI) system.
7 8
Sucrose preference test. The sucrose preference test was conducted based on previously described 3 7 9 procedures 21 . Briefly, the mice or rats were habituated to a 1% sucrose solution for 2 days before 2 3 8 0 additional days of choice testing. The position of the water and sucrose bottles was switched every 12 h 3 8 1 to ensure that the mice or rats did not develop a side preference. After this period, the mice or rats were 3 8 2 deprived of food and water for 24 h, and exposed to two bottles filled with either 1% sucrose or water for 3 8 3 12 h in the dark. Total consumption of each fluid was measured and sucrose preference was calculated 3 8 4 as a percentage (amount of sucrose consumed (bottle A) × 100 / total volume consumed (bottles A + B)).
8 5
To avoid the bias related to body weight, this variable was calculated as an amount of consumed 3 8 6 sucrose in mg per gram body weight × 100. The CSDS protocol was conducted as previously described 20 . Briefly, a singly C57BL/6J mouse was 3 9 0 exposed to a different aggressive CD1 mouse for 5 min each day for a total of 10 days. Following 5 min 3 9 1 of contact, the intruder mouse was housed across a perforated plastic divider that allowed visual, 3 9 2 olfactory and auditory contacts, but prevented physical interaction from the aggressor CD1 mouse, for 3 9 3 the remainder of the 24-h period. Non-defeated control mice were housed opposite to another C57BL/6 3 9 4 mouse and the controls were changed daily. Following the 10-day CSDS protocol, the avoidance 3 9 5
behaviors were tested to separate the susceptible and unsusceptible subpopulations, the interaction 3 9 6 ratio was then calculated as 100 × (time spent in the interaction zone with an "Target")/(time spent in the 3 9 7 interaction zone with "No Target") and an interaction ratio of 100 was set as a cutoff. The mice with used for qRT-PCR assays were designed and their sequences are listed in Supplementary Table S3 .
5 3
The expression levels of these genes were normalized to that of beta-actin and the fold changes in gene 4 5 4 expression were computed by setting the gene expression levels in control samples as one. incubated with primary antibodies overnight at 4°C, followed by incubation with the secondary antibodies.
7 7
The following antibodies are used: p-CREB S133 (Abcam, cat. no. ab32096, 1:250), CREB (Abcam, cat. quantification of BrdU-labeled cells, a modified unbiased stereology protocol was used as described 4 9 9 previously 51 . Briefly, we collected 5 rats for each group. One in six series of sections of each brain were
counted in the dentate gyrus throughout the hippocampus. Results were multiplied by ten to obtain the 5 0 1 total number of BrdU-positive cells per dentate gyrus. The average of these values for the individual 5 0 2 brain was used for statistical analysis. To determine the effects of drugs on the depression rats, we measured the levels of the negative ionization modes, which were used for detection (Agilent Technologies). For both platforms, 5 1 5
results were denoted as data matrices, in which integrated peak areas were used for determining the 5 1 6 metabolites in all the samples. where cor(e i ,e j ) is the expression Spearman's correlation coefficient (SCC) between gene i and j in 5 7 6 control or depression group. The power value of β is set as 2 in order to emphasize large correlations at 5 7 7 the expense of low correlations. For a specific gene i, we defined a WGCNA score (WGCNA i ) to evaluate 5 7 8 its edge weight difference between the control and depression coexpression networks (Eq. (2)),
where m is the number of genes in a coexpression network, a i and a' i are the edge weights between 5 8 1 gene i with other genes in the control and depression coexpression networks, respectively. It is worth 5 8 2
noting that we introduced a weighted factor (w i,k ) in the WGCNA score instead of using the original 
